Centessa Pharmaceuticals (CNTA)
NASDAQ: CNTA
· Real-Time Price · USD
18.03
0.39 (2.21%)
At close: Aug 15, 2025, 3:59 PM
18.05
0.11%
After-hours: Aug 15, 2025, 04:34 PM EDT
Centessa Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.14M | -111.33M | -42.57M | -43.82M | -38.05M | -37.16M | -38.65M | -24.89M | -50.71M | -43.17M | -53.88M | -64.66M | -54.5M | -60.91M | -39.97M | -41.37M | -240.29M |
Depreciation & Amortization | 217K | 227.87K | 236K | 236K | 240K | 248.14K | 238K | 237K | 89K | 36K | 35K | 32K | 28K | 12.01K | 12.94K | 7K | 2.01K |
Stock-Based Compensation | 7.88M | 8.33M | 8.45M | 8.61M | 8.15M | 7.43M | 7.56M | 7.21M | 7.19M | 6.62M | 7.03M | 5.6M | 5.72M | 4.76M | 4.13M | 3.23M | 2.73M |
Other Working Capital | n/a | 37.15M | 255K | -3.7M | -6.13M | 3.93M | -4.53M | -4.08M | 1.81M | -16.64M | 3.93M | 4.65M | -1.13M | -5.42M | 4.95M | -3.72M | 5.54M |
Other Non-Cash Items | n/a | 34.39M | -570K | -290.05K | 1.1M | 1.96M | 795K | 2.67M | 975K | 1.86M | 800K | -7.35M | 1.08M | 3.09M | 11.89M | 17.75M | 225.8M |
Deferred Income Tax | 995K | 388.98K | 1.25M | 567K | 434K | -135.33K | -2.89M | -23.64M | n/a | -2.86M | -135K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 25.2M | 11.8M | -5.89M | -9.17M | -3.45M | -4.45M | -5.66M | -5.38M | -14.04M | 7.06M | 6.5M | -2.35M | -1.94M | -138.49K | -6.98M | 3.68M |
Operating Cash Flow | -57.25M | -42.8M | -21.39M | -40.58M | -37.29M | -31.1M | -37.39M | -44.06M | -47.84M | -51.56M | -39.09M | -59.88M | -50.02M | -56.29M | -33.32M | -33.87M | -12.67M |
Capital Expenditures | n/a | -1.08 | -34K | 1.55 | -0.47 | -28.03K | -43K | -10K | -88K | -652K | -16K | -229K | -240K | -63.7K | -48.23K | -36.92K | -37.13K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 18.25M | -86.63M | n/a | n/a | n/a | n/a | n/a | n/a | -153.75K | 99.8K | -285.81K | 63.77M |
Purchase of Investments | -222.39M | 572.56K | 146.83M | -120.53M | -20M | -70.24M | -37.5M | -71.09M | -86.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 24.41M | 45M | 65.13M | 36.76M | 51.98M | 86.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 587.71K | -146.83M | -52.9K | 16.76M | -18.25M | 86.25M | -71.09M | -86.25M | 206K | n/a | n/a | n/a | 4.6M | n/a | -112K | -4.48M |
Investing Cash Flow | -222.39M | 25M | 44.96M | -55.46M | 16.76M | -18.29M | 48.71M | -71.1M | -86.34M | -446K | -16K | -229K | -240K | -217.44K | 51.57K | -322.74K | 63.74M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 73.64M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.08 | -18.88 | -12.01K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.09M | 2.99M | 3.27M | -1.96M | 838K | 118K | 180K | 12K | n/a | 89K | 224K | 70K | 74K | 295.68K | -295.68K | 345.41M | 241.89M |
Financial Cash Flow | 3.09M | 2.96M | 245.98M | 105.31M | 10.49M | 6.38M | 14.74M | 12K | n/a | 89K | 224K | 70K | 74K | 73M | -1.07M | 345.41M | 242.73M |
Net Cash Flow | -278.06M | -11.8M | 267.65M | 9.15M | -9.81M | -43.47M | 26.28M | -114.77M | -133.66M | -51.2M | -39.32M | -60.3M | -50.62M | 16.27M | -41.2M | 308.89M | 291.38M |
Free Cash Flow | -57.25M | -42.8M | -21.42M | -40.58M | -37.29M | -31.13M | -37.44M | -44.07M | -47.93M | -52.22M | -39.1M | -60.11M | -50.26M | -56.35M | -33.37M | -33.9M | -12.7M |